Shaun Lanceine Meek, LCMFT | |
107 W 3rd Ave, Caney, KS 67333-1301 | |
(620) 515-1907 | |
(620) 222-9316 |
Full Name | Shaun Lanceine Meek |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 107 W 3rd Ave, Caney, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194150102 | NPI | - | NPPES |
201085550A | Medicaid | KS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 2557 (Kansas) | Secondary |
106H00000X | Marriage & Family Therapist | 2733 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Shaun Lanceine Meek, LCMFT Po Box 103, Caney, KS 67333-0103 Ph: (620) 515-1907 | Shaun Lanceine Meek, LCMFT 107 W 3rd Ave, Caney, KS 67333-1301 Ph: (620) 515-1907 |
News Archive
The Global AIDS Alliance (GAA) commends the bi-partisan congressional leadership that it has taken to introduce the International Violence Against Women Act (I-VAWA) today. Violence against women has a major impact on the ability of women and girls to access healthcare globally.
Johns Hopkins scientists who specialize in unconventional hunts for genetic information outside nuclear DNA sequences have bagged a weighty quarry 13 genes linked to human body mass. The experiments screened the so called epigenome for key information that cells remember other than the DNA code itself and may have serious implications for preventing and treating obesity, the investigators say.
First, Computerworld reports, "Verizon announced on Wednesday a new cloud-based service offering for healthcare providers that will handle the sharing of patient information electronically between disparate platforms. The new service, called the Verizon Health Information Exchange, consolidates clinical patient data from various providers and translates it into a standardized format that can then be accessed via a secure Web portal" (Mearian, 7/14).
Data demonstrating the effectiveness of KALBITOR (ecallantide) to treat hereditary angioedema (HAE) acute attacks by primary attack location were provided in an oral presentation yesterday at the American Academy of Allergy, Asthma and Immunology 2010 Annual Meeting in New Orleans.
› Verified 5 days ago